Biotechnology News

- Patients who responded to afami-cel had longer progression-free survival (median 58 weeks) compared to non-responders (median 12 weeks) -- Responses occurred across subgroups, with greater response rates associated with lower baseline tumor burden, fewer prior lines of therapy, and higher MAGE-A4 expression -- Afami-cel demonstrated a favorable benefit:risk profile...
Biotechnology, Healthcare and Hospitals
2022-05-26 5:00 PM EDT | Adaptimmune Therapeutics PLC

Toronto, Ontario--(Newsfile Corp. - May 26, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction, announced today the filing of a Patent Cooperation Treaty (PCT) application for the treatment of behavioral addictions with ketamine and...
Technology, Biotechnology, Health
2022-05-26 7:30 AM EDT | Awakn Life Sciences Corp.

Vancouver, British Columbia--(Newsfile Corp. - May 25, 2022) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), a federally regulated manufacturer and distributor of cannabis vapes and oils, announced today the Jamaica Intellectual Property Office has granted Nextleaf a patent for the Company's foundational process...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2022-05-25 9:15 AM EDT | Nextleaf Solutions Ltd.

Jackson Center, Pennsylvania--(Newsfile Corp. - May 24, 2022) - Halberd Corporation (OTC Pink: HALB) researchers have demonstrated a protocol which allows for the precise level of elimination of a specific targeted cytokine from a homogeneous mixture of two different cytokines in a fluid. Several adverse health conditions are caused...
Biotechnology, Pharmaceuticals, Health
2022-05-24 8:00 AM EDT | Halberd Corp.

Vancouver, British Columbia--(Newsfile Corp. - May 24, 2022) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a western Canadian based life sciences company aimed at developing non-addictive chronic pain and relapse preventing products announces that its strategic partners Symeres are licensed to produce large quantities of controlled...
Biotechnology, Pharmaceuticals
2022-05-24 7:32 AM EDT | Nirvana Life Sciences Inc.

Toronto, Ontario--(Newsfile Corp. - May 24, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is pleased to announce that the company's CEO, Anthony Tennyson, will...
Technology, Biotechnology, Health
2022-05-24 7:30 AM EDT | Awakn Life Sciences Corp.

Halifax, Nova Scotia--(Newsfile Corp. - May 19, 2022) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces the termination of its licensing agreement with Arlington Scientific for the Company's COVID-19 rapid saliva test following its analysis of data from two clinicial studies and consultations with the...
Biotechnology, Health
2022-05-19 5:27 PM EDT | Sona Nanotech Inc.

Calgary, Alberta--(Newsfile Corp. - May 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce a non-brokered private placement of up to 15 Million Units priced in the context of the market. Each Unit consists of one common share in the...
Biotechnology, Pharmaceuticals, Health
2022-05-19 4:55 PM EDT | Hemostemix Inc.

Calgary, Alberta--(Newsfile Corp. - May 19, 2022) -   Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the appointment of Mr. Peter Pavlin, P.Eng. to the position of Vice President Operations.Mr. Pavlin earned his Bachelor of Applied Science and Master of Engineering degrees in...
Biotechnology, Pharmaceuticals, Health
2022-05-19 11:29 AM EDT | Hemostemix Inc.

Toronto, Ontario--(Newsfile Corp. - May 19, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announced today the completion of the world's first ketamine treatment study...
Technology, Biotechnology, Health
2022-05-19 7:55 AM EDT | Awakn Life Sciences Corp.

Oakville, Ontario--(Newsfile Corp. - May 19, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce that its Board of...
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2022-05-19 7:27 AM EDT | Cardiol Therapeutics Inc.

Toronto, Ontario--(Newsfile Corp. - May 18, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") is pleased to announced that Cybeats has joined Next Generation Manufacturing Canada (NGen)[1], an organization that delivers funding, education, mentorship and development initiatives across Canada.NGen supports development of world-leading advanced manufacturing...
Biotechnology, Healthcare and Hospitals, Health
2022-05-18 4:05 PM EDT | Scryb Inc.

The Company is issuing a clarification news release at the request of IIROC.Vancouver, British Columbia--(Newsfile Corp. - May 18, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceuticals company primarily focused on the development of novel immune-oncology vaccines and drug...
Biotechnology, Pharmaceuticals, Health
2022-05-18 11:30 AM EDT | Defence Therapeutics Inc.

Jackson Center, Pennsylvania--(Newsfile Corp. - May 18, 2022) - Halberd Corporation (OTC Pink: HALB) has engaged the services of mdi Consultants, Inc. (mdi) to assist Halberd in navigating the U.S. Food and Drug Administration's (FDA) complex application and certification processes. mdi will guide Halberd on the FDA application and...
Biotechnology, Pharmaceuticals, Health
2022-05-18 8:00 AM EDT | Halberd Corp.

Toronto, Ontario--(Newsfile Corp. - May 18, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that Concierge Medical Consultants Inc. ("Concierge") has been capitalizing on the lucrative custom care market and has been extensively growing its client base to help provide personalized...
Technology, Biotechnology
2022-05-18 3:00 AM EDT | ScreenPro Security Inc.

Toronto, Ontario--(Newsfile Corp. - May 18, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") is pleased to report on the signing of software evaluation licence agreement for Cybeats cybersecurity platform with a global leader in building technologies and security equipment that is...
Biotechnology, Healthcare and Hospitals, Health
2022-05-18 3:00 AM EDT | Scryb Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 17, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the development of novel dual-acting AccumTM-linked protein...
Biotechnology, Pharmaceuticals, Health
2022-05-17 4:30 PM EDT | Defence Therapeutics Inc.

Cincinnati, Ohio--(Newsfile Corp. - May 17, 2022) - CTI Clinical Trial and Consulting Services (CTI), a global research service provider, will relocate and expand its European laboratory. The new facility, located in Bizkaia Technology Park in Bilbao, Spain, will increase the laboratory footprint by more than 500%. The expanded footprint...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2022-05-17 4:01 PM EDT | CTI Clinical Trial & Consulting

Vancouver, British Columbia--(Newsfile Corp. - May 17, 2022) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a Canadian based life sciences company aimed at developing non-addictive chronic pain and relapse preventing products, is pleased to announce that it has signed a letter of intent with Innovate...
Biotechnology, Pharmaceuticals
2022-05-17 9:00 AM EDT | Nirvana Life Sciences Inc.